Literature DB >> 12859163

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Andrew S Levey1, Josef Coresh, Ethan Balk, Annamaria T Kausz, Adeera Levin, Michael W Steffes, Ronald J Hogg, Ronald D Perrone, Joseph Lau, Garabed Eknoyan.   

Abstract

Chronic kidney disease is a worldwide public health problem with an increasing incidence and prevalence, poor outcomes, and high cost. Outcomes of chronic kidney disease include not only kidney failure but also complications of decreased kidney function and cardiovascular disease. Current evidence suggests that some of these adverse outcomes can be prevented or delayed by early detection and treatment. Unfortunately, chronic kidney disease is underdiagnosed and undertreated, in part as a result of lack of agreement on a definition and classification of its stages of progression. Recent clinical practice guidelines by the National Kidney Foundation 1) define chronic kidney disease and classify its stages, regardless of underlying cause, 2) evaluate laboratory measurements for the clinical assessment of kidney disease, 3) associate the level of kidney function with complications of chronic kidney disease, and 4) stratify the risk for loss of kidney function and development of cardiovascular disease. The guidelines were developed by using an approach based on the procedure outlined by the Agency for Healthcare Research and Quality. This paper presents the definition and five-stage classification system of chronic kidney disease and summarizes the major recommendations on early detection in adults. Recommendations include identifying persons at increased risk (those with diabetes, those with hypertension, those with a family history of chronic kidney disease, those older than 60 years of age, or those with U.S. racial or ethnic minority status), detecting kidney damage by measuring the albumin-creatinine ratio in untimed ("spot") urine specimens, and estimating the glomerular filtration rate from serum creatinine measurements by using prediction equations. Because of the high prevalence of early stages of chronic kidney disease in the general population (approximately 11% of adults), this information is particularly important for general internists and specialists.

Entities:  

Mesh:

Year:  2003        PMID: 12859163     DOI: 10.7326/0003-4819-139-2-200307150-00013

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  1228 in total

1.  Editor's Choice - Renal complications after EVAR with suprarenal versus infrarenal fixation among all users and routine users.

Authors:  S L Zettervall; S E Deery; P A Soden; K Shean; J J Siracuse; M Alef; V I Patel; M L Schermerhorn
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-08-02       Impact factor: 7.069

2.  Oral status, quality of life, and anxiety and depression in hemodialysis patients and the effect of the duration of treatment by dialysis on these variables.

Authors:  F Camacho-Alonso; C Cánovas-García; C Martínez-Ortiz; T De la Mano-Espinosa; T Ortuño-Celdrán; J I Marcello-Godino; R Ramos-Sánchez; M Sánchez-Siles
Journal:  Odontology       Date:  2017-08-02       Impact factor: 2.634

3.  Primary care management of chronic kidney disease.

Authors:  Adrienne S Allen; John P Forman; E John Orav; David W Bates; Bradley M Denker; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2010-10-05       Impact factor: 5.128

4.  Predictors of successful completion of diagnostic home sleep testing in patients with chronic kidney disease.

Authors:  Jonathan Lee; Tanvir C Turin; David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Abul K Azad; Patrick J Hanly
Journal:  Sleep Breath       Date:  2014-11-05       Impact factor: 2.816

5.  For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics.

Authors:  Andrew D Rule; Kent R Bailey; Gary L Schwartz; Sundeep Khosla; John C Lieske; L Joseph Melton
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

6.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

7.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

8.  Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.

Authors:  Lloyd Mulenga; Patrick Musonda; Albert Mwango; Michael J Vinikoor; Mary-Ann Davies; Aggrey Mweemba; Alexandra Calmy; Jeffrey S Stringer; Olivia Keiser; Benjamin H Chi; Gilles Wandeler
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

9.  Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.

Authors:  Nathalie H Urrunaga; Laurence S Magder; Matthew R Weir; Don C Rockey; Ayse L Mindikoglu
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

10.  Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience.

Authors:  Ercan Malkoc; Daniel Ramirez; Onder Kara; Matthew J Maurice; Ryan J Nelson; Peter A Caputo; Jihad H Kaouk
Journal:  World J Urol       Date:  2016-09-23       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.